Study Site 112 — Tulsa, Oklahoma

Study Site 112 is a clinical research site located in Tulsa, Oklahoma, United States 74136.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site 112 has participated in 3 clinical trials.

Therapeutic areas: Refractory Chronic Cough, Pruritus, Prurigo Nodularis.

Sponsors: Vyne Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 112?

Study Site 112 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 112 conducted?

Study Site 112 has 3 clinical trials on record. Their work covers Refractory Chronic Cough, Pruritus, Prurigo Nodularis.

Is Study Site 112 accredited by Crixeo Health?

Study Site 112 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 112?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.